Moss, 7 April 2025
Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction has been completed by a close associate of a primary insider in Gentian:
Kjersti Grimsrud, a board member and primary insider in Gentian, has purchased 5,000 shares in Gentian at NOK 46.20 per share.
PCA notification pursuant to the EU Market Abuse Regulation Article 19 is attached.
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.
For further information, please contact:
Njaal Kind, Group CFO,
njaal.kind@gentian.no
+47 91 90 65 25